What is Morgans saying about Cochlear, Deep Yellow, and Webjet shares?

Morgans has been very busy running the rule over a number of ASX shares this month.

Three that the broker has been looking at are in this article. Let’s see whether it rates them as buys, holds, or sells. Here’s what you need to know:

Cochlear Ltd (ASX: COH)

Morgans was a touch disappointed with this hearing solutions company’s half-year results. It notes that the Nucleus Nexa system was to blame, with contracting taking longer than anticipated.

In response to its results, the broker has retained its hold rating with a trimmed price target of $214.93. It said:

The 1H26 result was softer than expected, with revenue, margins and profit negatively impacted mainly on longer than anticipated contracting for the newly launched Nucleus Nexa system (Nexa). Soft Cochlear Implants (CI) growth mis-matched sales, reflecting unfavourable emerging market mix and delayed developed market momentum, while Services was flat and Acoustics surprised to downside on increased competitive pressures.

While Nexa adoption accelerated late in the half and management maintained FY26 guidance, but now is targeting the lower end of the range, it increases reliance on a strong 2H recovery which appears optimistic, especially in light of flat GM and FX headwinds. We adjust our FY26-28 estimates and lower our target price to A$214.93. We maintain a cautious stance, but move to HOLD on share weakness.

Deep Yellow Ltd (ASX: DYL)

Another ASX share that Morgans has been looking at is uranium developer Deep Yellow.

The broker has made some changes to its financial model to reflect first production timing, its cash balance, and its uranium price assumptions. This has resulted in the broker retaining its speculative buy rating with an improved price target of $2.56. It said:

We update our outlook and forecasts for DYL to reflect a series of changes at the corporate, project and macro level since our last update. Key revisions include adjustments to first production timing at Tumas, cash position and an uplift to our bull-case uranium price assumption. We maintain our SPECULATIVE BUY rating and increase our price target to A$2.56ps (from A$1.92ps).

Webjet Group Ltd (ASX: WJL)

A third ASX share Morgans has been looking at is online travel agent Webjet. It notes that takeover talks have ended and Webjet has downgraded its earnings guidance.

The broker appears to believe that this may not be the last downgrade and has concerns over cyclical and structural threats. As a result, it has put a hold rating and 61 cents price target on its shares. It said:

WJL announced that potential takeover discussions with both Helloworld (HLO) and BGH Capital have ceased. WJL has downgraded its FY26 EBITDA guidance by another 7-9%. Earnings uncertainty remains high given cyclical and structural threats and at a time when WJL is investing in its business for longer term success. Given WJL is no longer in play, focus returns to the fundamentals of the business which look challenged in the near term. We retain a Hold rating with a new price target of A$0.61.

The post What is Morgans saying about Cochlear, Deep Yellow, and Webjet shares? appeared first on The Motley Fool Australia.

More reading

• Where to next for Webjet shares after a 26% crash?
• Leading brokers name 3 ASX shares to buy today
• Where to from here for Cochlear shares?
• Utilities outperform as ASX 200 ascends to a 3-month high
• Why Austal, Cochlear, Nick Scali, and WiseTech shares are tumbling today

Motley Fool contributor James Mickleboro has positions in Cochlear. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Cochlear. The Motley Fool Australia has recommended Cochlear. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.